Published in J Virol on September 01, 2001
VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection. J Virol (2004) 1.89
Characterization of a UL49-null mutant: VP22 of herpes simplex virus type 1 facilitates viral spread in cultured cells and the mouse cornea. J Virol (2006) 1.36
White spot syndrome virus protein ICP11: A histone-binding DNA mimic that disrupts nucleosome assembly. Proc Natl Acad Sci U S A (2008) 1.16
Sequential localization of two herpes simplex virus tegument proteins to punctate nuclear dots adjacent to ICP0 domains. J Virol (2002) 1.15
Herpes simplex virus tegument protein VP22 contains overlapping domains for cytoplasmic localization, microtubule interaction, and chromatin binding. J Virol (2002) 1.11
Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen. J Virol (2002) 0.98
The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator. J Virol (2006) 0.96
Herpes simplex virus 1 VP22 regulates translocation of multiple viral and cellular proteins and promotes neurovirulence. J Virol (2012) 0.90
Deletion of the herpes simplex virus 1 UL49 gene results in mRNA and protein translation defects that are complemented by secondary mutations in UL41. J Virol (2012) 0.87
Bovine herpesvirus tegument protein VP22 enhances thymidine kinase/ganciclovir suicide gene therapy for neuroblastomas compared to herpes simplex virus VP22. J Virol (2004) 0.82
Characterization of the nuclear localization and nuclear export signals of bovine herpesvirus 1 VP22. J Virol (2005) 0.81
Cell cycle modulation by Marek's disease virus: the tegument protein VP22 triggers S-phase arrest and DNA damage in proliferating cells. PLoS One (2014) 0.80
The CBP co-activator is a histone acetyltransferase. Nature (1997) 10.91
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature (1996) 10.81
Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell (1996) 9.86
Structure of chromatin. Annu Rev Biochem (1977) 8.91
Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (1998) 8.75
Nucleosome structure. Annu Rev Biochem (1980) 7.16
Kinetic analysis of translocation through nuclear pore complexes. EMBO J (2001) 5.27
Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell (1999) 5.23
The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell (1996) 5.20
Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell (1999) 4.83
Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature (1996) 4.70
Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell (1997) 4.51
Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev (2000) 4.00
Facilitated nuclear transport of histone H1 and other small nucleophilic proteins. Cell (1990) 3.28
HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol (1999) 3.21
VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells. J Virol (1995) 2.76
The importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone H1. EMBO J (1999) 2.31
Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotechnol (1998) 1.99
Role of covalent modifications of histones in regulating gene expression. Gene (1999) 1.92
Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection. J Virol (1999) 1.82
Characterization of bovine herpesvirus 1 UL49 homolog gene and product: bovine herpesvirus 1 UL49 homolog is dispensable for virus growth. J Virol (1995) 1.48
Cytoplasm-to-nucleus translocation of a herpesvirus tegument protein during cell division. J Virol (2000) 1.45
Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther (1999) 1.29
Evaluation of VP22 spread in tissue culture. J Virol (2000) 1.25
Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. J Virol (2000) 1.20
Long-distance transcriptional enhancement by the histone acetyltransferase PCAF. Proc Natl Acad Sci U S A (1998) 1.19
Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells. Gene Ther (1998) 1.16
Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle. Vaccine (1997) 1.12
Mapping of linear histone regions exposed at the surface of the nucleosome in solution. J Mol Biol (1997) 0.94
Nuclear transport of H1 histones meets the criteria of a nuclear localization signal-mediated process. J Cell Biochem (1997) 0.84
CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur J Immunol (1995) 1.75
Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine (1996) 1.70
Development of a diagnostic test for Johne's disease using a DNA hybridization probe. J Clin Microbiol (1989) 1.52
Rapid lysis technique for mycobacterial species. J Clin Microbiol (1987) 1.41
The development and analysis of species specific and cross reactive monoclonal antibodies to leukocyte differentiation antigens and antigens of the major histocompatibility complex for use in the study of the immune system in cattle and other species. Vet Immunol Immunopathol (1987) 1.34
Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one- and two-dimensional cellular immunoblotting. Infect Immun (1992) 1.25
Lymphokine-induced inhibition of growth of Eimeria bovis and Eimeria papillata (Apicomplexa) in cultured bovine monocytes. Infect Immun (1985) 1.21
Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. J Virol (2000) 1.20
Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus. J Virol (1996) 1.14
Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum Gene Ther (1995) 1.11
Expression of tfx and sensitivity to the rhizobial peptide antibiotic trifolitoxin in a taxonomically distinct group of alpha-proteobacteria including the animal pathogen Brucella abortus. Appl Environ Microbiol (1994) 1.06
Isolation of Brucella abortus ssb and uvrA genes from a genomic library by use of lymphocytes as probes. Infect Immun (1993) 1.02
The role of T cell subsets and cytokines in the regulation of intracellular bacterial infection. Braz J Med Biol Res (1998) 1.01
Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response. Vaccine (1997) 0.98
Determination of bovine lymphocyte responses to extracted proteins of Brucella abortus by using protein immunoblotting. Infect Immun (1988) 0.97
Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs. Cell Immunol (1996) 0.97
Tyrosine phosphorylation of bovine herpesvirus 1 tegument protein VP22 correlates with the incorporation of VP22 into virions. J Virol (2001) 0.97
Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein. Infect Immun (1994) 0.97
Functional and phenotypic characterization of WC1+ gamma/delta T cells isolated from Babesia bovis-stimulated T cell lines. Cell Immunol (1994) 0.95
Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J Virol (2000) 0.95
Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies. J Virol (1995) 0.95
Endometriosis in four irradiated rhesus monkeys. Vet Pathol (1972) 0.93
Sodium dodecyl sulfate- and salt-extracted antigens from various Brucella species induce proliferation of bovine lymphocytes. Infect Immun (1992) 0.93
Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells. Immunology (1994) 0.91
Collaboration of bovine T lymphocytes and macrophages in T-lymphocyte response to Brucella abortus. Infect Immun (1986) 0.90
Bovine interleukin 2 (IL-2) production and activity on bovine and murine cell lines. Vet Immunol Immunopathol (1984) 0.89
Brucella abortus tandem repeated ATP-binding proteins, BapA and BapB, homologs of haemophilus influenzae LktB, are not necessary for intracellular survival. Microb Pathog (2000) 0.88
Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice. Infect Immun (2009) 0.88
Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis. J Virol (1998) 0.88
Bovine herpesvirus-1 infects activated CD4+ lymphocytes. J Gen Virol (1997) 0.86
Two molecularly independent surface receptors identify bovine T lymphocytes. J Immunol Methods (1981) 0.86
Bovine leukemia virus transmembrane protein gp30 physically associates with the down-regulatory phosphatase SHP-1. Cell Immunol (1999) 0.85
Induction of MHC-unrestricted cytolytic CD4+ T cells against virally infected target cells by cross-linking CD4 molecules. J Immunol (1994) 0.85
Residual virulence of Brucella abortus in the absence of the cytochrome bc(1)complex in a murine model in vitro and in vivo. Microb Pathog (2000) 0.84
A genetic immunization adjuvant system based on BVP22-antigen fusion. Hum Gene Ther (2001) 0.84
Monoclonal antibodies to ovine SBU-T8 and SBU-T6 bind analogous molecules on bovine lymphocytes. Immunology (1989) 0.84
Biolistic-mediated gene transfer using the bovine herpesvirus-1 glycoprotein D is an effective delivery system to induce neutralizing antibodies in its natural host. J Immunol Methods (2000) 0.83
Generalized amyloidosis in a rhesus monkey. Lab Anim Sci (1972) 0.82
Impairment of MHC class I transcription in a mutant bovine B cell line. Immunogenetics (1992) 0.82
Mapping T and B lymphocyte epitopes of bovine herpesvirus-1 glycoprotein B. J Gen Virol (1999) 0.82
Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and -10. J Virol (1999) 0.82
Bovine naturally cytolytic cell activation against bovine herpes virus type 1-infected cells does not require late viral glycoproteins. Immunology (1989) 0.81
Regulation of transgene expression in genetic immunization. Braz J Med Biol Res (1999) 0.81
Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies. J Virol (1998) 0.81
A simple method for specific depletion of B lymphocytes from bovine peripheral blood mononuclear cells. Immunol Commun (1980) 0.81
Characterization of bovine mononuclear cell populations with natural cytolytic activity against bovine herpesvirus 1-infected cells. Cell Immunol (1989) 0.81
Transplantation tolerance: Lyt-1+2- helper T cells require a second proliferation signal to overcome Lyt- 1-2+ suppressor T cell activity. J Immunol (1983) 0.81
Transplantation tolerance: evidence for Lyt 1+,2-,Qa 1.2+ Suppressor-inducer T cells in allogeneic thymus-grafted nude mice. Cell Immunol (1983) 0.81
Bovine T lymphocyte response to bovine herpesvirus-1: cell phenotypes, viral recognition and acid-labile interferon production. Vet Immunol Immunopathol (1986) 0.80
gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host. J Virol (2000) 0.80
CD8+ lymphocytes that kill allogeneic and xenogeneic major histocompatibility complex class I targets. Hum Immunol (1995) 0.80
Comparison of bovine mononuclear cells with other species for cytolytic activity against virally-infected cells. Vet Immunol Immunopathol (1989) 0.79
Concanavalin A-induced bovine suppressor cells: cellular interaction and regulation. Adv Exp Med Biol (1981) 0.79
Bovine natural killer-like cell responses against cell lines expressing recombinant bovine herpesvirus type 1 glycoproteins. J Immunol (1990) 0.79
Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1. J Virol (1997) 0.79
Membranous glomerulonephritis in dogs infected with Dirofilaria immitis. Vet Pathol (1975) 0.79
Analysis of workshop antibodies to null cells on a non-T/non-B lymphocyte population. Vet Immunol Immunopathol (1991) 0.79
Suppression of bovine T- and B-lymphocyte responses by fetuin, a bovine glycoprotein. Cell Immunol (1982) 0.79
Lytic function of bovine lymphokine-activated killer cells from a normal and a malignant catarrhal fever virus-infected animal. Vet Immunol Immunopathol (1988) 0.78
Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host. Vaccine (1994) 0.78
The differentiation of bone marrow cells to functional T lymphocytes following implantation of thymus grafts and thymic stroma in nude and ATxBM mice. Cell Immunol (1977) 0.78
Bovine con A-induced suppressor cells: generation, macrophage requirements and possible mechanisms of regulatory action. Immunology (1981) 0.78
Optimization of lymphocyte proliferation assay for cells with high spontaneous proliferation in vitro: CD4+ T cell proliferation in bovine leukemia virus infected animals with persistent lymphocytosis. J Immunol Methods (1996) 0.78
BHV-1 glycoprotein 1 and recombinant interleukin 1 beta efficiently elicit mucosal IgA response. Vaccine (1995) 0.78
CD4(+) cytotoxic T-lymphocyte activity against macrophages pulsed with bovine herpesvirus 1 polypeptides. J Virol (1998) 0.78
Recombinant herpesviral proteins produced by cell-free translation provide a novel approach for the mapping of T lymphocyte epitopes. J Immunol (1990) 0.78
Localization of antigen-specific lymphocytes following lymph node challenge. Immunology (1986) 0.78
Coccidioides immitis encephalitis in two dogs. J Am Vet Med Assoc (1972) 0.78
Suppressor T cells in thymus-reconstituted nude mice: regulation of mitogen-induced transformation. Cell Immunol (1980) 0.78
Killer cells of feline leukemia virus- and feline sarcoma virus-infected transformed cells: the role of NK, ADCC, and in vitro generated cytotoxic cells. Cell Immunol (1985) 0.77
Loss of MHC I transcription trans-activator in the bovine B-LCL, BL3.1. Vet Immunol Immunopathol (1996) 0.77
The bovine major histocompatibility complex (BoLa): close linkage of the genes controlling serologically defined antigens and mixed lymphocyte reactivity. Immunogenetics (1981) 0.77
Ameloblastic odontoma in a rhesus monkey. J Am Vet Med Assoc (1972) 0.77
Effect of monoclonal antibodies on in vitro function of T-cell subsets. Vet Immunol Immunopathol (1991) 0.76
The human homologue of the bovine leukemia virus receptor BLVRcp1 is the delta-subunit of adaptor-related AP-3 protein that does not bind the BVLgp51. Arch Virol (1999) 0.76
The bovine p150/95 molecule (CD11c/CD18) functions in primary cell-cell interaction. Vet Immunol Immunopathol (1991) 0.76
Constitutively expressing cell lines that secrete a truncated bovine herpes virus-1 glycoprotein (gpI) stimulate T-lymphocyte responsiveness. Immunology (1992) 0.75
Evaluation of functional thymic hormones in Arabian horses with severe combined immunodeficiency. Clin Exp Immunol (1979) 0.75
Biochemical and functional characterization of 8-10C5 (gp120,90), a novel molecule on the surface of bovine T leucocytes. Immunology (1990) 0.75
Sequence and rate of postmortem autolysis in guinea pig liver. Am J Vet Res (1974) 0.75
Arabian horses with severe combined immunodeficiency -- evaluation of functional thymic hormones. Dev Comp Immunol (1979) 0.75
Individual antigens of cattle. Antibodies to non-clustered bovine antigens. Vet Immunol Immunopathol (1991) 0.75
Biochemical analysis of bovine T cell antigens with workshop monoclonal antibodies. Vet Immunol Immunopathol (1991) 0.75
A method for the rapid identification of T lymphocyte epitopes. Pept Res (1992) 0.75
Pneumothorax associated with lung mite lesions in a rhesus monkey. Lab Anim Sci (1973) 0.75
Evaluation of reconstitution of immunodeficient mice by partially purified thymic extracts. Am J Vet Res (1978) 0.75
CD5dim peripheral blood lymphocytes proliferate to exogenous IL-2 in the absence of antigen and kill in an NK-like manner. Cell Immunol (1990) 0.75
Identification of two independent MHC class II antigens in a bovine lymphoblastoid cell line. Vet Immunol Immunopathol (1989) 0.75
Bovine mixed leukocyte response: effect of selected parameters on cell responses. Vet Immunol Immunopathol (1981) 0.75
A novel population of cells in the peripheral blood of a cow with a neurofibrosarcoma. Vet Immunol Immunopathol (1990) 0.75
Bovine NK and LAK susceptibility is independent of class I expression on B lymphoblastoid variants. Vet Immunol Immunopathol (1994) 0.75
Reduction of class I expression in a bovine B-lymphoblastoid cell line is locus specific. Hum Immunol (1994) 0.75